Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study.

OBJECTIVE Schizophrenia is associated with premature mortality, but the specific causes and pathways are unclear. The authors used outpatient and inpatient data for a national population to examine the association between schizophrenia and mortality and comorbidities. METHOD This was a national cohort study of 6,097,834 Swedish adults, including 8,277 with schizophrenia, followed for 7 years (2003-2009) for mortality and comorbidities diagnosed in any outpatient or inpatient setting nationwide. RESULTS On average, men with schizophrenia died 15 years earlier, and women 12 years earlier, than the rest of the population, and this was not accounted for by unnatural deaths. The leading causes were ischemic heart disease and cancer. Despite having twice as many health care system contacts, schizophrenia patients had no increased risk of nonfatal ischemic heart disease or cancer diagnoses, but they had an elevated mortality from ischemic heart disease (adjusted hazard ratio for women, 3.33 [95% CI=2.73-4.05]; for men, 2.20 [95% CI=1.83-2.65]) and cancer (adjusted hazard ratio for women, 1.71 [95% CI=1.38-2.10; for men, 1.44 [95% CI=1.15-1.80]). Among all people who died from ischemic heart disease or cancer, schizophrenia patients were less likely than others to have been diagnosed previously with these conditions (for ischemic heart disease, 26.3% compared with 43.7%; for cancer, 73.9% compared with 82.3%). The association between schizophrenia and mortality was stronger among women and the employed. Lack of antipsychotic treatment was also associated with elevated mortality. CONCLUSIONS Schizophrenia patients had markedly premature mortality, and the leading causes were ischemic heart disease and cancer, which appeared to be underdiagnosed. Preventive interventions should prioritize primary health care tailored to this population, including more effective risk modification and screening for cardiovascular disease and cancer.

[1]  P. Sullivan,et al.  Cigarettes and oral snuff use in Sweden: Prevalence and transitions. , 2006, Addiction.

[2]  P. Sparén,et al.  Time trends in schizophrenia mortality in Stockholm County, Sweden: cohort study , 2000, BMJ : British Medical Journal.

[3]  D. Tsoi,et al.  Interventions for smoking cessation and reduction in individuals with schizophrenia. , 2013, The Cochrane database of systematic reviews.

[4]  B. Druss,et al.  Quality of medical care and excess mortality in older patients with mental disorders. , 2001, Archives of general psychiatry.

[5]  M. Heo,et al.  Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.

[6]  Aaron D. J. Frost,et al.  Cancer incidence in patients with schizophrenia and their first‐degree relatives – a meta‐analysis , 2008, Acta psychiatrica Scandinavica.

[7]  Herng‐Ching Lin,et al.  An increased risk of stroke among young schizophrenia patients , 2008, Schizophrenia Research.

[8]  Herng‐Ching Lin,et al.  Poor clinical outcomes among pneumonia patients with schizophrenia. , 2011, Schizophrenia bulletin.

[9]  P. Mortensen,et al.  Increased mortality among patients admitted with major psychiatric disorders: a register-based study comparing mortality in unipolar depressive disorder, bipolar affective disorder, schizoaffective disorder, and schizophrenia. , 2007, The Journal of clinical psychiatry.

[10]  Preben Bo Mortensen,et al.  The occurence of cancer in first admitted schizophrenic patients , 1994, Schizophrenia Research.

[11]  J. Sundquist,et al.  Gestational age at birth and mortality in young adulthood. , 2011, JAMA.

[12]  C. Gasse,et al.  Chronic Somatic Comorbidity and Excess Mortality Due to Natural Causes in Persons with Schizophrenia or Bipolar Affective Disorder , 2011, PloS one.

[13]  R. Woolson,et al.  Medical comorbidity in women and men with schizophrenia , 2006, Journal of General Internal Medicine.

[14]  J. Ludvigsson,et al.  External review and validation of the Swedish national inpatient register , 2011, BMC public health.

[15]  E. Leinonen,et al.  Mortality and causes of death in older patients with schizophrenia , 2012, International journal of geriatric psychiatry.

[16]  Mogens Vestergaard,et al.  Life expectancy and cardiovascular mortality in persons with schizophrenia , 2012, Current opinion in psychiatry.

[17]  F. Chou,et al.  The incidence and relative risk of stroke in patients with schizophrenia: A five-year follow-up study , 2012, Schizophrenia Research.

[18]  A. Tanskanen,et al.  Incidence of cancer among persons with schizophrenia and their relatives. , 2001, Archives of general psychiatry.

[19]  H. Inskip,et al.  Twenty-five year mortality of a community cohort with schizophrenia , 2010, British Journal of Psychiatry.

[20]  J. Suvisaari,et al.  Five-year follow-up study of disability pension rates in first-onset schizophrenia with special focus on regional differences and mortality. , 2011, General hospital psychiatry.

[21]  J. Leon,et al.  A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors , 2005, Schizophrenia Research.

[22]  B. Druss,et al.  Mental disorders and quality of diabetes care in the veterans health administration. , 2002, The American journal of psychiatry.

[23]  P. Mortensen,et al.  Somatic hospital contacts, invasive cardiac procedures, and mortality from heart disease in patients with severe mental disorder. , 2009, Archives of general psychiatry.

[24]  J. Birtwistle,et al.  The unhealthy lifestyle of people with schizophrenia , 1999, Psychological Medicine.

[25]  J. Tiihonen,et al.  Cardiovascular morbidity, mortality and pharmacotherapy in patients with schizophrenia , 2012, Psychological Medicine.

[26]  Antti Tanskanen,et al.  11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study) , 2009, The Lancet.

[27]  L. Gunning-Schepers,et al.  Differences between studies in reported relative risks associated with smoking: an overview. , 1996, Public health reports.

[28]  E. Yano,et al.  Use of general medical services by VA patients with psychiatric disorders. , 2002, Psychiatric services.

[29]  C. Holman,et al.  Death rate from ischaemic heart disease in Western Australian psychiatric patients 1980-1998. , 2003, The British journal of psychiatry : the journal of mental science.

[30]  S. Saha,et al.  A systematic review of mortality in schizophrenia: is the differential mortality gap worsening over time? , 2007, Archives of general psychiatry.

[31]  B. Barraclough,et al.  Excess mortality of mental disorder , 1998, British Journal of Psychiatry.

[32]  J. Newcomer,et al.  The Metabolic Effects of Antipsychotic Medications , 2006, Canadian journal of psychiatry. Revue canadienne de psychiatrie.

[33]  C Michael Stein,et al.  Atypical antipsychotic drugs and the risk of sudden cardiac death. , 2009, The New England journal of medicine.

[34]  C. Fox,et al.  Identifying Barriers and Facilitating Factors to Improve Screening Mammography Rates in Women Diagnosed with Mental Illness and Substance Use Disorders , 2006, Women & health.

[35]  Andrea C. Fernandes,et al.  All-cause mortality among people with serious mental illness (SMI), substance use disorders, and depressive disorders in southeast London: a cohort study , 2010, BMC psychiatry.

[36]  P. Qin.  The impact of psychiatric illness on suicide: differences by diagnosis of disorders and by sex and age of subjects. , 2011, Journal of psychiatric research.

[37]  J. Sundquist,et al.  Neighborhood deprivation and psychiatric medication prescription: a Swedish national multilevel study. , 2011, Annals of epidemiology.

[38]  P. Boyle,et al.  Cancer, cigarette smoking and premature death in Europe: a review including the Recommendations of European Cancer Experts Consensus Meeting, Helsinki, October 1996. , 1997, Lung cancer.

[39]  J. Sundquist,et al.  Preterm birth and psychiatric medication prescription in young adulthood: a Swedish national cohort study. , 2010, International journal of epidemiology.

[40]  M. Vares,et al.  Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses , 2005, Nordic journal of psychiatry.

[41]  C. Hennekens,et al.  Schizophrenia and increased risks of cardiovascular disease. , 2005, American heart journal.

[42]  O. Mors,et al.  The schizophrenic patient in the somatic hospital , 2000, Acta psychiatrica Scandinavica. Supplementum.

[43]  J. Suvisaari,et al.  Mortality among patients with schizophrenia and reduced psychiatric hospital care , 2005, Psychological Medicine.

[44]  K. Kendler,et al.  Incidence of cancer in patients with schizophrenia and their first-degree relatives: a population-based study in Sweden. , 2013, Schizophrenia bulletin.

[45]  M. Goldacre,et al.  Mortality after hospital discharge for people with schizophrenia or bipolar disorder: retrospective study of linked English hospital episode statistics, 1999-2006 , 2011, BMJ : British Medical Journal.